Differences in pandemic influenza vaccination policies for pregnant women in Europe

BMC Public Health

Volumn 11, Issue , 2011, Pages

  Luteijn, Johannes M ^a   Dolk, Helen ^a   Marnoch, Gordon J ^a  

^a UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT;

ARTICLE; EUROPE; FEMALE; HUMAN; IMMUNOLOGY; INFLUENZA; INFLUENZA VIRUS A H1N1; MANAGEMENT; POLICY; PREGNANCY; PREGNANCY COMPLICATION; QUESTIONNAIRE; VIROLOGY;

ANTIVIRAL AGENTS; EUROPE; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; POLICY MAKING; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PUBLIC POLICY; QUESTIONNAIRES;

EID: 80054692302     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-11-819     Document Type: Article

References (37)

1. Influenza vaccination in pregnancy: current evidence and selected national policies. Mak TK, Mangtani P, Leese J, Watson JM, Pfeifer D, Lancet Infect Dis 2008 8 44 52 10.1016/S1473-3099(07)70311-0 18156088 (Pubitemid 351620939)
2. Novel H1N1 virus infection and pregnancy. Satpathy HK, Lindsay M, Kawwass JF, Postgrad Med 2009 121 106 112 19940421
3. 2009 H1N1 influenza A and pregnancy outcomes in Victoria, Australia. Hewagama S, Walker SP, Stuart RL, Gordon C, Johnson PD, Friedman ND, O'Reilly M, Cheng AC, Giles ML, Clin Infect Dis 2010 50 686 690 10.1086/650460 20100064
4. H1N1 2009 influenza virus infection during pregnancy in the USA. Jamieson DJ, Honein MA, Rasmussen SA, Williams JL, Swerdlow DL, Biggerstaff MS, Lindstrom S, Louie JK, Christ CM, Bohm SR, Fonseca VP, Ritger KA, Kuhles DJ, Eggers P, Bruce H, Davidson HA, Lutterloh E, Harris ML, Burke C, Cocoros N, Finelli L, MacFarlane KF, Shu B, Olsen SJ, Novel Influenza A (H1N1) Pregnancy Working Group, Lancet 2009 374 451 458 10.1016/S0140-6736(09)61304-0 19643469
5. Vaccination strategies against pandemic (H1N1) 2009 accompanying the communication from the commission to the European Parliament, the council, the European Economic and Social Committee and the Committee of the regions. Pandemic (H1N1) 2009. European Commission (EC), http://ec.europa.eu/health/ archive/ph-threats/com/influenza/docs/flu-staff5-en.pdf
6. Experts advise WHO on pandemic vaccine policies and strategies. Pandemic (H1N1) 2009 briefing note 2. World Health Organization, http://www.who.int/csr/ disease/swineflu/notes/h1n1-vaccine-20090713/en/index.html
7. Paper 1: The EUROCAT network - organization and processes. Boyd PA, Haeusler M, Barisic I, Loane M, Garne E, Dolk H, Birth Defects Res A Clin Mol Teratol 2011 91 Suppl 1 2 15 21384531
8. VOLUME 9A of The Rules Governing Medicines Products in the European Union:-Guidelines on Pharmacovigilance for Medicinal Products for Human Use. European Commission (EC), http://ec.europa.eu/health/files/eudralex/vol-9/pdf/ vol9a-09-2008-en.pdf
9. Population and risk group uptake of H1N1 influenza vaccine in mainland France 2009-2010: results of a national vaccination campaign. Bone A, Guthmann JP, Nicolau J, Levy-Bruhl D, Vaccine 2010 28 8157 8161 10.1016/j.vaccine.2010. 09.096 20937310
10. [Influenza vaccination of pregnant women and the experiences related to the pandemic influenza A-virus H1N1 infection in Hungary, 2009]. Czeizel E, Lege Artis Med 2011 21 89 95 English abstract, article in Hungarian 21710706
11. European 2009 Influenza Pandemic Timeline. European Centre for Disease Prevention and Control (ECDC), http://www.ecdc.europa.eu/en/healthtopics/H1N1/ Documents/110810-2009-pandemic-European-Timeline.pdf
12. Determinants of non-vaccination against pandemic 2009 H1N1 influenza in pregnant women: a prospective cohort study. Freund R, Le RC, Charlier C, Avenell C, Truster V, Treluyer JM, Skalli D, Ville Y, Goffinet F, Launay O, Inserm COFLUPREG Study Group, PLoS One 2011 6 20900 10.1371/journal.pone.0020900 21695074
13. [Evaluation of the influenza a H1N1 vaccination in Castilla and Leon regions, Spain]. Perez-Rubio A, Eiros Bouza JM, Castrodeza Sanz JJ, Med Clin (Barc) 2010 135 543 545 [English abstract, article in Spanish] 10.1016/j.medcli.2010.05.016
14. Swine flu vaccination during pregnancy, follow-up data-preliminary results of the surveillance project of the Berlin institute for clinical teratology and drug risk assessment in pregnancy. Schaefer C, Facts, Views and Vision in Obstetrics and Gynaecology 2011 3S 2 12
15. Monitoring pandemic influenza A(H1N1) vaccination coverage in Germany 2009/10-results from thirteen consecutive cross-sectional surveys. Walter D, Bohmer MM, Heiden M, Reiter S, Krause G, Wichmann O, Vaccine 2011 29 4008 4012 10.1016/j.vaccine.2011.03.069 21463683
16. Influenza A/H1N1v in pregnancy: an investigation of the characteristics and management of affected women and the relationship to pregnancy outcomes for mother and infant. Yates L, Pierce M, Stephens S, Mill AC, Spark P, Kurinczuk JJ, Valappil M, Brocklehurst P, Thomas SH, Knight M, Health Technol Assess 2010 14 109 182 20630123
17. Baxter Sent Bird Flu Virus to European Labs by Error (Update2). Bloomberg, http://www.bloomberg.com/apps/news?pid=newsarchive&sid= aTo3LbhcA75I
18. Differences in national influenza vaccination policies across the European Union, Norway and Iceland 2008-2009. Mereckiene J, Cotter S, D'Ancona F, Giambi C, Nicoll A, Levy-Bruhl D, Lopalco PL, Weber JT, Johansen K, Dematte L, Salmaso S, Stefanoff P, Greco D, Dorleans F, Polkowska A, O'Flanagan D, VENICE project gatekeepers group, Euro Surveill 2010 15 44 19700 21087586
19. Positive attitudes of French general practitioners towards A/H1N1 influenza-pandemic vaccination: a missed opportunity to increase vaccination uptakes in the general public? Schwarzinger M, Verger P, Guerville MA, Aubry C, Rolland S, Obadia Y, Moatti JP, Vaccine 2010 28 2743 2748 10.1016/j.vaccine. 2010.01.027 20117271
20. Pandemic (H1N1) 2009 influenza vaccine uptake in pregnant women entering the 2010 influenza season in Western Australia. White SW, Petersen RW, Quinlivan JA, Med J Aust 2010 193 405 407 20919972
21. Determinants of A (H1N1) vaccination: cross-sectional study in a population of pregnant women in Quebec. Fabry P, Gagneur A, Pasquier JC, Vaccine 2011 29 1824 1829 10.1016/j.vaccine.2010.12.109 21219988
22. The 2009 A(H1N1) pandemic in Europe. European Centre for Disease Prevention and Control (ECDC), 2011 http://ecdc.europa.eu/en/publications/ Publications/101108-SPR-pandemic-experience.pdf
23. Influenza vaccination during pregnancy and factors for lacking compliance with current CDC guidelines. Panda B, Stiller R, Panda A, J Matern Fetal Neonatal Med 2011 24 402 406 10.3109/14767058.2010.497882 20593974
24. Delivering influenza vaccine to pregnant women. Naleway AL, Smith WJ, Mullooly JP, Epidemiol Rev 2006 28 47 53 10.1093/epirev/mxj002 16731574 (Pubitemid 44289088)
25. An adjuvanted pandemic influenza H1N1 vaccine provides early and long term protection in health care workers. Madhun AS, Akselsen PE, Sjursen H, Pedersen G, Svindland S, Nostbakken JK, Nilsen M, Mohn K, Jul-Larsen A, Smith I, Major D, Wood J, Cox RJ, Vaccine 2010 29 266 273 10.1016/j.vaccine.2010.10.038 21034828
26. Lessons learnt from pandemic A(H1N1) 2009 influenza vaccination. Highlights of a European workshop in Brussels (22 March 2010). Hanquet G, Van DP, Brasseur D, De C, Gregor S, Holmberg M, Martin R, Molnár Z, Pompa MG, Snacken R, van der Sande M, Van Ranst M, Wirtz A, Neels P, Vaccine 2011 29 370 377 10.1016/j.vaccine.2010.10.079 21075164
27. Response to a monovalent 2009 influenza A (H1N1) vaccine. Greenberg ME, Lai MH, Hartel GF, Wichems CH, Gittleson C, Bennet J, Dawson G, Hu W, Leggio C, Washington D, Basser RL, N Engl J Med 2009 361 2405 2413 10.1056/NEJMoa0907413 19745216
28. Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine. Clark TW, Pareek M, Hoschler K, Dillon H, Nicholson KG, Groth N, Stephenson I, N Engl J Med 2009 361 2424 2435 10.1056/NEJMoa0907650 19745215
29. Exposure to MF59-adjuvanted influenza vaccines during pregnancy - a retrospective analysis. Tsai T, Kyaw MH, Novicki D, Nacci P, Rai S, Clemens R, Vaccine 2010 28 1877 1880 10.1016/j.vaccine.2009.11.077 19969117
30. Adjuvants and alternative routes of administration towards the development of the ideal influenza vaccine. Durando P, Iudici R, Alicino C, Alberti M, Florentiis DD, Ansaldi F, Icardi G, Hum Vaccin 2011 7 1S 1 2
31. The evidence for the safety of thiomersal in newborn and infant vaccines. Clements CJ, Vaccine 2004 22 1854 1861 10.1016/j.vaccine.2003.11.017 15121295 (Pubitemid 38581053)
32. Vaccination, squalene and anti-squalene antibodies: facts or fiction? Lippi G, Targher G, Franchini M, Eur J Intern Med 2010 21 70 73 10.1016/j.ejim.2009.12.001 20206873
33. National seasonal influenza vaccination survey in Europe, 2008. Mereckiene J, Cotter S, Nicoll A, Levy-Bruhl D, Ferro A, Tridente G, Zanoni G, Berra P, Salmaso S, O'Flanagan D, O Flanagan D, VENICE Project Gatekeepers Group, Euro Surveill 2008 13 43 19017 18947524
34. Crude birth rates 2009 and total population. European Commission (EC) Eurostat, 2009 http://epp.eurostat.ec.europa.eu/portal/page/portal/population/ data/main-tables
35. Pandemic influenza 2009 on Reunion Island: A mild wave linked to a low reproduction number. Renault P, D'Ortenzio E, Kermarec F, Filleul L, PLoS Curr 2010 2 RN1145 20126277
36. Telephone survey to assess uptake of seasonal, pandemic influenza and pneumococcal vaccines in Ireland during the 2009/2010 influenza season. Mereckiene J, Cotter S, O'Donnell J, Igoe D, O'Hara A, O'Flanagan D, http://www.ecdc.europa.eu/en/eurovaccine/Documents/Eurovaccine2010-Mereckiene-2. pdf
37. National Summary of Influenza Pandemic (H1N1) 2009 vaccination in Ireland- Provisional data. Cotter S, Gee S, O'Lorcain P, Epi-Insight 2010 11 9 http://ndsc.newsweaver.ie/epiinsight/viz7qx9a6lrqkeph6tk9uv